The Poc Hba1C Testing by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Poc Hba1C Testing Market:
https://www.thebusinessresearchcompany.com/report/poc-hba1c-testing-global-market-report
According to The Business Research Company’s Poc Hba1C Testing, The poc hba1c testing market size has grown rapidly in recent years. It will grow from $0.85 billion in 2023 to $0.95 billion in 2024 at a compound annual growth rate (CAGR) of 12.0%. The growth in the historic period can be attributed to strong economic growth in emerging markets, increase in diabetes prevalence, rise in covid-19 cases and increase in disposable income.
The poc hba1c testing market size is expected to see rapid growth in the next few years. It will grow to $1.46 billion in 2028 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to rising government support, increasing prevalence of diabetes- type ii diabetes, easy accessibility of poc tests and faster availability of results in poc testing than conventional laboratory testing procedures. Major trends in the forecast period include focus on hba1c microfluidic immunofluorescence test, increasing use of home collection hba1c testing kits, focus on hba1c test using capillary electrophoresis technology and advances in testing technologies.
The increasing prevalence of diabetes is expected to propel the growth of the POC HbA1C testing market. Long working hours, less physical activity, and unhealthy eating and drinking habits are increasing the prevalence of diabetes. Diabetes can be diagnosed and monitored with point-of-care (POC) HbA1c assays, which can be utilized in community settings and healthcare facilities without laboratories. For instance, in December 2021, according to the International Diabetes Federation, a US-based intergovernmental organization, approximately 537 million adults (20-79 years old) are suffering from diabetes 2021, which is expected to reach 643 million by 2030, and 783 million by 2045. Therefore, the increasing prevalence of diabetes is driving the growth of the POC HbA1C testing market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=6833&type=smp
The poc hba1c testing market covered in this report is segmented –
1)By Type of Product: Instruments, Consumables
2)By Technology: Ion-Exchange HPLC, Enzymatic Assay, Affinity Binding Chromatography, Immunoassay, Other Technologies
3)By End User: Hospitals, Physician Office/Outpatient Center, Home Care, Other End Users
Technological advances are a key trend gaining popularity in the POC HbA1C testing market. Major players in the market are investing in developing advanced technologies to provide fast, accurate results in a short period thereby helping laboratories to manage the increase in demand for testing. For instance, Abbott, a US-based medical devices and health care company, introduced Afinion™ HbA1c Dx assay, an in vitro diagnostic test for the quantitative determination of HbA1c in human venous and capillary whole blood for use on the Afinion 2 Analyzer, and also Afinion AS100 Analyzer. The Afinion HbA1c Dx assay is the only rapid POC test cleared by the U.S. Food and Drug Administration (FDA) to assist healthcare professionals in diagnosing diabetes and determining the patient’s risk of developing the disorder. The test provides reliable and accurate results of 1,2 glycated hemoglobin in just three minutes, helping physicians evaluate patients and enabling them to formulate individualized care plans during a single visit to the doctor`s office.
The poc hba1c testing market report table of contents includes:
1. Executive Summary
2.Poc Hba1C Testing Market Characteristics
3.Poc Hba1C Testing Market Trends And Strategies
4.Poc Hba1C Testing Market analysis
5.Poc Hba1C Testing Market Size And Growth
6.Poc Hba1C Testing Segmentation
7.Poc Hba1C Testing Regional And Country Analysis
.
.
.
27. Poc Hba1C Testing Competitive Landscape And Company Profiles
28. Poc Hba1C Testing Key Mergers And Acquisitions
29.Poc Hba1C Testing Future Outlook and Potential Analysis
TOP MAJOR PLAYERS:
- F. Hoffmann-La Roche Ltd.
- Siemens Healthineers AG
- Bio-Rad Laboratories Inc.
- Menarini Group
- Danaher Corporation
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
